Asset manager Organon Capital reached a 5.04% stake in Valid's (VLID3) common shares on November 19, 2026. The investment funds and managed portfolios under its management came to hold 4,020,000 ON (common) shares, crossing the threshold that requires disclosure of a material stake.

Organon Capital stated that the increase in its stake is not intended to change Valid's control structure or the company's administrative structure.

Source: Notice to the Market, filed with the CVM on 11/19/2026 19:00. View original document

For information only; not investment advice.

Is VLID3 worth investing in?

VLID3Valid · B3
Price
R$ 14.88
as of 11/18/2026
Dividend yield
12.54 %
P/L
5.21
P/VPA
0.66
View full analysis of VLID3